nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.1	0.136	CbGbCtD
Cefdinir—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0894	0.121	CbGbCtD
Cefdinir—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0864	0.117	CbGbCtD
Cefdinir—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0797	0.108	CbGbCtD
Cefdinir—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.077	0.104	CbGbCtD
Cefdinir—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.076	0.103	CbGbCtD
Cefdinir—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0686	0.0929	CbGbCtD
Cefdinir—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0655	0.0887	CbGbCtD
Cefdinir—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0513	0.0695	CbGbCtD
Cefdinir—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0442	0.0599	CbGbCtD
Cefdinir—MPO—artery—type 2 diabetes mellitus	0.00222	0.157	CbGeAlD
Cefdinir—MPO—endothelium—type 2 diabetes mellitus	0.00187	0.133	CbGeAlD
Cefdinir—MPO—Vitamin B12 Metabolism—MAT1A—type 2 diabetes mellitus	0.0015	0.0288	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MAT1A—type 2 diabetes mellitus	0.00122	0.0235	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CBS—type 2 diabetes mellitus	0.00118	0.0227	CbGpPWpGaD
Cefdinir—Cefazolin—PON1—type 2 diabetes mellitus	0.00101	0.61	CrCbGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.001	0.0193	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CBS—type 2 diabetes mellitus	0.000962	0.0185	CbGpPWpGaD
Cefdinir—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000953	0.0677	CbGeAlD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000932	0.0179	CbGpPWpGaD
Cefdinir—SLC15A1—kidney—type 2 diabetes mellitus	0.000837	0.0595	CbGeAlD
Cefdinir—MPO—cardiovascular system—type 2 diabetes mellitus	0.00077	0.0547	CbGeAlD
Cefdinir—MPO—Selenium Micronutrient Network—CBS—type 2 diabetes mellitus	0.000764	0.0147	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTR—type 2 diabetes mellitus	0.000762	0.0146	CbGpPWpGaD
Cefdinir—MPO—kidney—type 2 diabetes mellitus	0.000753	0.0535	CbGeAlD
Cefdinir—MPO—pancreas—type 2 diabetes mellitus	0.000748	0.0531	CbGeAlD
Cefdinir—MPO—Vitamin B12 Metabolism—HBA1—type 2 diabetes mellitus	0.000742	0.0143	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—INSR—type 2 diabetes mellitus	0.000733	0.0141	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—F7—type 2 diabetes mellitus	0.000708	0.0136	CbGpPWpGaD
Cefdinir—SLC15A2—retina—type 2 diabetes mellitus	0.000632	0.0449	CbGeAlD
Cefdinir—MPO—Vitamin B12 Metabolism—PLAT—type 2 diabetes mellitus	0.000631	0.0121	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTR—type 2 diabetes mellitus	0.00062	0.0119	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—HBA1—type 2 diabetes mellitus	0.000604	0.0116	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000601	0.0116	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—INSR—type 2 diabetes mellitus	0.000597	0.0115	CbGpPWpGaD
Cefdinir—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000596	0.0423	CbGeAlD
Cefdinir—MPO—Folate Metabolism—F7—type 2 diabetes mellitus	0.000576	0.0111	CbGpPWpGaD
Cefdinir—SLC22A5—retina—type 2 diabetes mellitus	0.00055	0.0391	CbGeAlD
Cefdinir—SLC15A1—liver—type 2 diabetes mellitus	0.000529	0.0376	CbGeAlD
Cefdinir—SLC15A2—kidney—type 2 diabetes mellitus	0.000523	0.0372	CbGeAlD
Cefdinir—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000518	0.0368	CbGeAlD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD1—type 2 diabetes mellitus	0.000514	0.00988	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—PLAT—type 2 diabetes mellitus	0.000513	0.00986	CbGpPWpGaD
Cefdinir—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.00051	0.0362	CbGeAlD
Cefdinir—MPO—Selenium Micronutrient Network—MTR—type 2 diabetes mellitus	0.000492	0.00946	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—HBA1—type 2 diabetes mellitus	0.00048	0.00922	CbGpPWpGaD
Cefdinir—MPO—liver—type 2 diabetes mellitus	0.000476	0.0338	CbGeAlD
Cefdinir—MPO—Vitamin B12 Metabolism—APOB—type 2 diabetes mellitus	0.000474	0.00911	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—INSR—type 2 diabetes mellitus	0.000474	0.0091	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000473	0.0091	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD2—type 2 diabetes mellitus	0.000463	0.0089	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—F7—type 2 diabetes mellitus	0.000458	0.00879	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—type 2 diabetes mellitus	0.000457	0.00879	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000456	0.00875	CbGpPWpGaD
Cefdinir—SLC22A5—kidney—type 2 diabetes mellitus	0.000455	0.0323	CbGeAlD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000449	0.00862	CbGpPWpGaD
Cefdinir—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000443	0.0315	CbGeAlD
Cefdinir—MPO—Folate Metabolism—SOD1—type 2 diabetes mellitus	0.000419	0.00804	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000416	0.008	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—CCL2—type 2 diabetes mellitus	0.000413	0.00792	CbGpPWpGaD
Cefdinir—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.00041	0.0291	CbGeAlD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00041	0.00787	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PLAT—type 2 diabetes mellitus	0.000408	0.00784	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTHFR—type 2 diabetes mellitus	0.000408	0.00783	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CAT—type 2 diabetes mellitus	0.000398	0.00764	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CRP—type 2 diabetes mellitus	0.000388	0.00745	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—APOB—type 2 diabetes mellitus	0.000386	0.00741	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—APOE—type 2 diabetes mellitus	0.00038	0.00729	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SOD2—type 2 diabetes mellitus	0.000377	0.00724	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—APOA1—type 2 diabetes mellitus	0.000375	0.00721	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3R1—type 2 diabetes mellitus	0.000368	0.00706	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—GPX1—type 2 diabetes mellitus	0.00036	0.00691	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ICAM1—type 2 diabetes mellitus	0.000357	0.00685	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—RELA—type 2 diabetes mellitus	0.000346	0.00665	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SOD1—type 2 diabetes mellitus	0.000333	0.00639	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTHFR—type 2 diabetes mellitus	0.000332	0.00637	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—INS—type 2 diabetes mellitus	0.000324	0.00623	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000323	0.00621	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CCL2—type 2 diabetes mellitus	0.000319	0.00613	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.000316	0.00607	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CRP—type 2 diabetes mellitus	0.000316	0.00606	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000311	0.00598	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GSTM1—type 2 diabetes mellitus	0.00031	0.00595	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.000307	0.00589	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—APOA1—type 2 diabetes mellitus	0.000305	0.00587	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.0003	0.00576	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.000299	0.00575	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000299	0.00575	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	0.000298	0.00572	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—type 2 diabetes mellitus	0.000297	0.00571	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NFKB1—type 2 diabetes mellitus	0.000292	0.00561	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ICAM1—type 2 diabetes mellitus	0.00029	0.00557	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000289	0.00555	CbGpPWpGaD
Cefdinir—SLC22A5—liver—type 2 diabetes mellitus	0.000288	0.0204	CbGeAlD
Cefdinir—MPO—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.000286	0.00549	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000278	0.00534	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000273	0.00525	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000268	0.00515	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	0.000268	0.00514	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000264	0.00507	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—INS—type 2 diabetes mellitus	0.000264	0.00507	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.000264	0.00506	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CCL2—type 2 diabetes mellitus	0.00026	0.00499	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	0.000251	0.00482	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	0.000243	0.00466	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	0.000242	0.00466	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—type 2 diabetes mellitus	0.000242	0.00465	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000236	0.00453	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000231	0.00444	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	0.00023	0.00443	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000228	0.00438	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—type 2 diabetes mellitus	0.000227	0.00436	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000227	0.00436	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	0.000226	0.00434	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000219	0.0042	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—RELA—type 2 diabetes mellitus	0.000218	0.00418	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000215	0.00413	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000212	0.00407	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000211	0.00405	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	0.00021	0.00403	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000208	0.004	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000207	0.00398	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	0.000206	0.00396	CbGpPWpGaD
Cefdinir—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Cefdinir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Cefdinir—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Cefdinir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000198	0.00102	CcSEcCtD
Cefdinir—Nausea—Repaglinide—type 2 diabetes mellitus	0.000198	0.00102	CcSEcCtD
Cefdinir—Asthenia—Glipizide—type 2 diabetes mellitus	0.000198	0.00102	CcSEcCtD
Cefdinir—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000197	0.00102	CcSEcCtD
Cefdinir—Pruritus—Glipizide—type 2 diabetes mellitus	0.000195	0.00101	CcSEcCtD
Cefdinir—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000195	0.001	CcSEcCtD
Cefdinir—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000194	0.001	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000193	0.00371	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	0.000193	0.0037	CbGpPWpGaD
Cefdinir—Flatulence—Metformin—type 2 diabetes mellitus	0.000193	0.000994	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—type 2 diabetes mellitus	0.000192	0.00369	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00098	CcSEcCtD
Cefdinir—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00019	0.000979	CcSEcCtD
Cefdinir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00019	0.000979	CcSEcCtD
Cefdinir—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000189	0.000976	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000189	0.000975	CcSEcCtD
Cefdinir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000189	0.000974	CcSEcCtD
Cefdinir—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000189	0.000974	CcSEcCtD
Cefdinir—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000188	0.000973	CcSEcCtD
Cefdinir—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000188	0.000969	CcSEcCtD
Cefdinir—Renal failure—Ramipril—type 2 diabetes mellitus	0.000187	0.000966	CcSEcCtD
Cefdinir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000187	0.000966	CcSEcCtD
Cefdinir—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000187	0.000965	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000187	0.00359	CbGpPWpGaD
Cefdinir—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000187	0.000964	CcSEcCtD
Cefdinir—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000187	0.000963	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000186	0.00358	CbGpPWpGaD
Cefdinir—Jaundice—Ramipril—type 2 diabetes mellitus	0.000186	0.000958	CcSEcCtD
Cefdinir—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000186	0.000958	CcSEcCtD
Cefdinir—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000185	0.000955	CcSEcCtD
Cefdinir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000185	0.000953	CcSEcCtD
Cefdinir—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000184	0.000953	CcSEcCtD
Cefdinir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00095	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—BCL2—type 2 diabetes mellitus	0.000184	0.00353	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—NFKB1—type 2 diabetes mellitus	0.000184	0.00353	CbGpPWpGaD
Cefdinir—Convulsion—Orlistat—type 2 diabetes mellitus	0.000184	0.000948	CcSEcCtD
Cefdinir—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000184	0.000948	CcSEcCtD
Cefdinir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000184	0.000948	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000183	0.000946	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IL6—type 2 diabetes mellitus	0.000183	0.00352	CbGpPWpGaD
Cefdinir—Chest pain—Valsartan—type 2 diabetes mellitus	0.000183	0.000943	CcSEcCtD
Cefdinir—Dizziness—Glipizide—type 2 diabetes mellitus	0.000182	0.000942	CcSEcCtD
Cefdinir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000182	0.00094	CcSEcCtD
Cefdinir—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000182	0.000938	CcSEcCtD
Cefdinir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000181	0.000933	CcSEcCtD
Cefdinir—Chest pain—Orlistat—type 2 diabetes mellitus	0.00018	0.000932	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000179	0.00344	CbGpPWpGaD
Cefdinir—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000179	0.000922	CcSEcCtD
Cefdinir—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000178	0.000917	CcSEcCtD
Cefdinir—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000177	0.000911	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000176	0.00338	CbGpPWpGaD
Cefdinir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000176	0.000909	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	0.000176	0.00337	CbGpPWpGaD
Cefdinir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000176	0.000906	CcSEcCtD
Cefdinir—Vomiting—Glipizide—type 2 diabetes mellitus	0.000175	0.000905	CcSEcCtD
Cefdinir—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000175	0.000904	CcSEcCtD
Cefdinir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000175	0.000902	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—PTGS2—type 2 diabetes mellitus	0.000175	0.00335	CbGpPWpGaD
Cefdinir—Rash—Glipizide—type 2 diabetes mellitus	0.000174	0.000898	CcSEcCtD
Cefdinir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000174	0.000897	CcSEcCtD
Cefdinir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000174	0.000896	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	0.000173	0.00332	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000173	0.000893	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000173	0.00332	CbGpPWpGaD
Cefdinir—Headache—Glipizide—type 2 diabetes mellitus	0.000173	0.000892	CcSEcCtD
Cefdinir—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000172	0.00089	CcSEcCtD
Cefdinir—Shock—Valsartan—type 2 diabetes mellitus	0.000172	0.000889	CcSEcCtD
Cefdinir—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000172	0.000887	CcSEcCtD
Cefdinir—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000171	0.000885	CcSEcCtD
Cefdinir—Flatulence—Losartan—type 2 diabetes mellitus	0.000171	0.000883	CcSEcCtD
Cefdinir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00017	0.000879	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.00017	0.00327	CbGpPWpGaD
Cefdinir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00017	0.000876	CcSEcCtD
Cefdinir—Agitation—Irbesartan—type 2 diabetes mellitus	0.000169	0.000875	CcSEcCtD
Cefdinir—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000169	0.000875	CcSEcCtD
Cefdinir—Hypertension—Metformin—type 2 diabetes mellitus	0.000169	0.000871	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	0.000168	0.00323	CbGpPWpGaD
Cefdinir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000168	0.000866	CcSEcCtD
Cefdinir—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000168	0.000866	CcSEcCtD
Cefdinir—Anorexia—Valsartan—type 2 diabetes mellitus	0.000167	0.000862	CcSEcCtD
Cefdinir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00086	CcSEcCtD
Cefdinir—Chest pain—Metformin—type 2 diabetes mellitus	0.000166	0.000859	CcSEcCtD
Cefdinir—Headache—Pioglitazone—type 2 diabetes mellitus	0.000166	0.000855	CcSEcCtD
Cefdinir—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000165	0.000852	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000165	0.000849	CcSEcCtD
Cefdinir—Nausea—Glipizide—type 2 diabetes mellitus	0.000164	0.000846	CcSEcCtD
Cefdinir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000164	0.000845	CcSEcCtD
Cefdinir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000163	0.000842	CcSEcCtD
Cefdinir—Constipation—Gliclazide—type 2 diabetes mellitus	0.000163	0.000841	CcSEcCtD
Cefdinir—Rash—Glimepiride—type 2 diabetes mellitus	0.000162	0.000838	CcSEcCtD
Cefdinir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000162	0.000837	CcSEcCtD
Cefdinir—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000162	0.000837	CcSEcCtD
Cefdinir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000162	0.000835	CcSEcCtD
Cefdinir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000162	0.000834	CcSEcCtD
Cefdinir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000162	0.000834	CcSEcCtD
Cefdinir—Headache—Glimepiride—type 2 diabetes mellitus	0.000161	0.000832	CcSEcCtD
Cefdinir—Headache—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00083	CcSEcCtD
Cefdinir—Agitation—Losartan—type 2 diabetes mellitus	0.000159	0.000823	CcSEcCtD
Cefdinir—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000159	0.000822	CcSEcCtD
Cefdinir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00082	CcSEcCtD
Cefdinir—Insomnia—Valsartan—type 2 diabetes mellitus	0.000158	0.000818	CcSEcCtD
Cefdinir—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000157	0.00081	CcSEcCtD
Cefdinir—Shock—Metformin—type 2 diabetes mellitus	0.000157	0.00081	CcSEcCtD
Cefdinir—Insomnia—Orlistat—type 2 diabetes mellitus	0.000156	0.000808	CcSEcCtD
Cefdinir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000156	0.000807	CcSEcCtD
Cefdinir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000156	0.000806	CcSEcCtD
Cefdinir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000156	0.000805	CcSEcCtD
Cefdinir—Somnolence—Valsartan—type 2 diabetes mellitus	0.000156	0.000804	CcSEcCtD
Cefdinir—Leukopenia—Losartan—type 2 diabetes mellitus	0.000155	0.000802	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000155	0.00298	CbGpPWpGaD
Cefdinir—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000154	0.000796	CcSEcCtD
Cefdinir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000154	0.000793	CcSEcCtD
Cefdinir—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000154	0.000793	CcSEcCtD
Cefdinir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000153	0.000789	CcSEcCtD
Cefdinir—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000153	0.000787	CcSEcCtD
Cefdinir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000152	0.000787	CcSEcCtD
Cefdinir—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000152	0.000786	CcSEcCtD
Cefdinir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000152	0.000786	CcSEcCtD
Cefdinir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000152	0.000786	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000152	0.00292	CbGpPWpGaD
Cefdinir—Anorexia—Metformin—type 2 diabetes mellitus	0.000152	0.000785	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000151	0.00078	CcSEcCtD
Cefdinir—Cefradine—CYP3A4—type 2 diabetes mellitus	0.000151	0.0908	CrCbGaD
Cefdinir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000151	0.000778	CcSEcCtD
Cefdinir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000151	0.000778	CcSEcCtD
Cefdinir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00015	0.000777	CcSEcCtD
Cefdinir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00015	0.000777	CcSEcCtD
Cefdinir—Pruritus—Glyburide—type 2 diabetes mellitus	0.00015	0.000775	CcSEcCtD
Cefdinir—Constipation—Valsartan—type 2 diabetes mellitus	0.00015	0.000773	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000149	0.000771	CcSEcCtD
Cefdinir—Shock—Irbesartan—type 2 diabetes mellitus	0.000148	0.000764	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000148	0.00284	CbGpPWpGaD
Cefdinir—Chest pain—Losartan—type 2 diabetes mellitus	0.000148	0.000763	CcSEcCtD
Cefdinir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000762	CcSEcCtD
Cefdinir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000147	0.000761	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000147	0.00282	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000147	0.00282	CbGpPWpGaD
Cefdinir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000756	CcSEcCtD
Cefdinir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000755	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	0.000146	0.0028	CbGpPWpGaD
Cefdinir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000145	0.000751	CcSEcCtD
Cefdinir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000145	0.00075	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000144	0.00278	CbGpPWpGaD
Cefdinir—Dry mouth—Losartan—type 2 diabetes mellitus	0.000144	0.000746	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000144	0.00276	CbGpPWpGaD
Cefdinir—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000143	0.000741	CcSEcCtD
Cefdinir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000143	0.000739	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—TNF—type 2 diabetes mellitus	0.000143	0.00275	CbGpPWpGaD
Cefdinir—Somnolence—Metformin—type 2 diabetes mellitus	0.000142	0.000732	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	0.000142	0.00272	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000142	0.000731	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000142	0.00272	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000141	0.00073	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000141	0.00271	CbGpPWpGaD
Cefdinir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00014	0.000725	CcSEcCtD
Cefdinir—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00014	0.000725	CcSEcCtD
Cefdinir—Shock—Losartan—type 2 diabetes mellitus	0.000139	0.000719	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000139	0.00267	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000139	0.000716	CcSEcCtD
Cefdinir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000139	0.000716	CcSEcCtD
Cefdinir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000138	0.000715	CcSEcCtD
Cefdinir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000712	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000138	0.000711	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000137	0.00264	CbGpPWpGaD
Cefdinir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000137	0.000706	CcSEcCtD
Cefdinir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000137	0.000706	CcSEcCtD
Cefdinir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000137	0.000706	CcSEcCtD
Cefdinir—Agitation—Ramipril—type 2 diabetes mellitus	0.000137	0.000706	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000136	0.00262	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000136	0.00262	CbGpPWpGaD
Cefdinir—Constipation—Metformin—type 2 diabetes mellitus	0.000136	0.000704	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000135	0.0026	CbGpPWpGaD
Cefdinir—Anorexia—Losartan—type 2 diabetes mellitus	0.000135	0.000697	CcSEcCtD
Cefdinir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000135	0.000697	CcSEcCtD
Cefdinir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000135	0.000696	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000134	0.00258	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000134	0.00258	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000134	0.00258	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000134	0.00258	CbGpPWpGaD
Cefdinir—Rash—Glyburide—type 2 diabetes mellitus	0.000134	0.000691	CcSEcCtD
Cefdinir—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000134	0.000691	CcSEcCtD
Cefdinir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000134	0.00069	CcSEcCtD
Cefdinir—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000133	0.000688	CcSEcCtD
Cefdinir—Headache—Glyburide—type 2 diabetes mellitus	0.000133	0.000686	CcSEcCtD
Cefdinir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000684	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000132	0.00253	CbGpPWpGaD
Cefdinir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000131	0.000675	CcSEcCtD
Cefdinir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000131	0.000675	CcSEcCtD
Cefdinir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00013	0.000673	CcSEcCtD
Cefdinir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00013	0.000673	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00013	0.000671	CcSEcCtD
Cefdinir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000129	0.000666	CcSEcCtD
Cefdinir—Convulsion—Ramipril—type 2 diabetes mellitus	0.000129	0.000666	CcSEcCtD
Cefdinir—Constipation—Irbesartan—type 2 diabetes mellitus	0.000129	0.000664	CcSEcCtD
Cefdinir—Insomnia—Losartan—type 2 diabetes mellitus	0.000128	0.000661	CcSEcCtD
Cefdinir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000127	0.000658	CcSEcCtD
Cefdinir—Chest pain—Ramipril—type 2 diabetes mellitus	0.000127	0.000654	CcSEcCtD
Cefdinir—Nausea—Glyburide—type 2 diabetes mellitus	0.000126	0.000651	CcSEcCtD
Cefdinir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000126	0.000651	CcSEcCtD
Cefdinir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000126	0.000651	CcSEcCtD
Cefdinir—Somnolence—Losartan—type 2 diabetes mellitus	0.000126	0.00065	CcSEcCtD
Cefdinir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000126	0.000649	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000125	0.0024	CbGpPWpGaD
Cefdinir—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000125	0.000644	CcSEcCtD
Cefdinir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000124	0.000641	CcSEcCtD
Cefdinir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000124	0.00064	CcSEcCtD
Cefdinir—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000124	0.00064	CcSEcCtD
Cefdinir—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000123	0.000636	CcSEcCtD
Cefdinir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000123	0.000635	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000123	0.00236	CbGpPWpGaD
Cefdinir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000122	0.000632	CcSEcCtD
Cefdinir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000121	0.000627	CcSEcCtD
Cefdinir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000121	0.000626	CcSEcCtD
Cefdinir—Constipation—Losartan—type 2 diabetes mellitus	0.000121	0.000625	CcSEcCtD
Cefdinir—Rash—Gliclazide—type 2 diabetes mellitus	0.00012	0.00062	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.00012	0.00231	CbGpPWpGaD
Cefdinir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00012	0.00062	CcSEcCtD
Cefdinir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00012	0.000619	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.00012	0.0023	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.00012	0.0023	CbGpPWpGaD
Cefdinir—Shock—Ramipril—type 2 diabetes mellitus	0.000119	0.000617	CcSEcCtD
Cefdinir—Headache—Gliclazide—type 2 diabetes mellitus	0.000119	0.000616	CcSEcCtD
Cefdinir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000614	CcSEcCtD
Cefdinir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000119	0.000614	CcSEcCtD
Cefdinir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000119	0.000614	CcSEcCtD
Cefdinir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000118	0.000611	CcSEcCtD
Cefdinir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000116	0.000598	CcSEcCtD
Cefdinir—Dizziness—Valsartan—type 2 diabetes mellitus	0.000116	0.000598	CcSEcCtD
Cefdinir—Anorexia—Ramipril—type 2 diabetes mellitus	0.000116	0.000598	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—IL6—type 2 diabetes mellitus	0.000115	0.00222	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000115	0.00221	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000115	0.00221	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000115	0.00221	CbGpPWpGaD
Cefdinir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000114	0.000591	CcSEcCtD
Cefdinir—Asthenia—Metformin—type 2 diabetes mellitus	0.000114	0.000591	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	0.000114	0.00218	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000113	0.00218	CbGpPWpGaD
Cefdinir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000113	0.000584	CcSEcCtD
Cefdinir—Pruritus—Metformin—type 2 diabetes mellitus	0.000113	0.000582	CcSEcCtD
Cefdinir—Cefazolin—ALB—type 2 diabetes mellitus	0.000113	0.0679	CrCbGaD
Cefdinir—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000112	0.000578	CcSEcCtD
Cefdinir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000112	0.000578	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000111	0.00214	CbGpPWpGaD
Cefdinir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000111	0.000575	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000111	0.00214	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000111	0.00214	CbGpPWpGaD
Cefdinir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000111	0.000572	CcSEcCtD
Cefdinir—Rash—Valsartan—type 2 diabetes mellitus	0.00011	0.00057	CcSEcCtD
Cefdinir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00011	0.000569	CcSEcCtD
Cefdinir—Vomiting—Orlistat—type 2 diabetes mellitus	0.00011	0.000568	CcSEcCtD
Cefdinir—Insomnia—Ramipril—type 2 diabetes mellitus	0.00011	0.000567	CcSEcCtD
Cefdinir—Headache—Valsartan—type 2 diabetes mellitus	0.00011	0.000566	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.00011	0.00211	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000109	0.0021	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000109	0.0021	CbGpPWpGaD
Cefdinir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000109	0.000563	CcSEcCtD
Cefdinir—Rash—Orlistat—type 2 diabetes mellitus	0.000109	0.000563	CcSEcCtD
Cefdinir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000109	0.000563	CcSEcCtD
Cefdinir—Headache—Orlistat—type 2 diabetes mellitus	0.000108	0.00056	CcSEcCtD
Cefdinir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000557	CcSEcCtD
Cefdinir—Somnolence—Ramipril—type 2 diabetes mellitus	0.000108	0.000557	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000107	0.00206	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000107	0.00206	CbGpPWpGaD
Cefdinir—Ceftriaxone—ALB—type 2 diabetes mellitus	0.000107	0.0644	CrCbGaD
Cefdinir—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000107	0.000552	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000107	0.00205	CbGpPWpGaD
Cefdinir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000106	0.00055	CcSEcCtD
Cefdinir—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000106	0.000545	CcSEcCtD
Cefdinir—Dizziness—Metformin—type 2 diabetes mellitus	0.000105	0.000544	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000105	0.00202	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000105	0.00202	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000105	0.00202	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000105	0.00202	CbGpPWpGaD
Cefdinir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000105	0.000541	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000105	0.00201	CbGpPWpGaD
Cefdinir—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000104	0.000539	CcSEcCtD
Cefdinir—Nausea—Valsartan—type 2 diabetes mellitus	0.000104	0.000537	CcSEcCtD
Cefdinir—Constipation—Ramipril—type 2 diabetes mellitus	0.000104	0.000536	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000103	0.00199	CbGpPWpGaD
Cefdinir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000103	0.000532	CcSEcCtD
Cefdinir—Nausea—Orlistat—type 2 diabetes mellitus	0.000103	0.000531	CcSEcCtD
Cefdinir—Asthenia—Losartan—type 2 diabetes mellitus	0.000102	0.000525	CcSEcCtD
Cefdinir—Vomiting—Metformin—type 2 diabetes mellitus	0.000101	0.000523	CcSEcCtD
Cefdinir—Rash—Metformin—type 2 diabetes mellitus	0.000101	0.000519	CcSEcCtD
Cefdinir—Dermatitis—Metformin—type 2 diabetes mellitus	0.0001	0.000519	CcSEcCtD
Cefdinir—Pruritus—Losartan—type 2 diabetes mellitus	0.0001	0.000517	CcSEcCtD
Cefdinir—Headache—Metformin—type 2 diabetes mellitus	9.99e-05	0.000516	CcSEcCtD
Cefdinir—Dizziness—Irbesartan—type 2 diabetes mellitus	9.95e-05	0.000514	CcSEcCtD
Cefdinir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000513	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	9.8e-05	0.00188	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	9.79e-05	0.00188	CbGpPWpGaD
Cefdinir—Cephalexin—CYP3A4—type 2 diabetes mellitus	9.76e-05	0.0588	CrCbGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	9.72e-05	0.00187	CbGpPWpGaD
Cefdinir—Diarrhoea—Losartan—type 2 diabetes mellitus	9.69e-05	0.0005	CcSEcCtD
Cefdinir—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000496	CcSEcCtD
Cefdinir—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000496	CcSEcCtD
Cefdinir—Vomiting—Irbesartan—type 2 diabetes mellitus	9.57e-05	0.000494	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	9.56e-05	0.00184	CbGpPWpGaD
Cefdinir—Rash—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.00049	CcSEcCtD
Cefdinir—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.000489	CcSEcCtD
Cefdinir—Nausea—Metformin—type 2 diabetes mellitus	9.47e-05	0.000489	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9.47e-05	0.00182	CbGpPWpGaD
Cefdinir—Headache—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000487	CcSEcCtD
Cefdinir—Cefalotin—ALB—type 2 diabetes mellitus	9.37e-05	0.0564	CrCbGaD
Cefdinir—Dizziness—Losartan—type 2 diabetes mellitus	9.36e-05	0.000483	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	9.16e-05	0.00176	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	9.1e-05	0.00175	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	9.08e-05	0.00174	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	9.08e-05	0.00174	CbGpPWpGaD
Cefdinir—Vomiting—Losartan—type 2 diabetes mellitus	9e-05	0.000465	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.95e-05	0.00172	CbGpPWpGaD
Cefdinir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000462	CcSEcCtD
Cefdinir—Nausea—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000461	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	8.93e-05	0.00172	CbGpPWpGaD
Cefdinir—Rash—Losartan—type 2 diabetes mellitus	8.93e-05	0.000461	CcSEcCtD
Cefdinir—Dermatitis—Losartan—type 2 diabetes mellitus	8.92e-05	0.000461	CcSEcCtD
Cefdinir—Headache—Losartan—type 2 diabetes mellitus	8.87e-05	0.000458	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	8.79e-05	0.00169	CbGpPWpGaD
Cefdinir—Asthenia—Ramipril—type 2 diabetes mellitus	8.71e-05	0.00045	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	8.64e-05	0.00166	CbGpPWpGaD
Cefdinir—Pruritus—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000444	CcSEcCtD
Cefdinir—Cephalexin—ALB—type 2 diabetes mellitus	8.51e-05	0.0513	CrCbGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	8.42e-05	0.00162	CbGpPWpGaD
Cefdinir—Nausea—Losartan—type 2 diabetes mellitus	8.41e-05	0.000434	CcSEcCtD
Cefdinir—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000429	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	8.29e-05	0.00159	CbGpPWpGaD
Cefdinir—Dizziness—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000415	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.88e-05	0.00151	CbGpPWpGaD
Cefdinir—Vomiting—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000399	CcSEcCtD
Cefdinir—Rash—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000395	CcSEcCtD
Cefdinir—Dermatitis—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000395	CcSEcCtD
Cefdinir—Headache—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000393	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.52e-05	0.00144	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.52e-05	0.00144	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	7.34e-05	0.00141	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.31e-05	0.0014	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.3e-05	0.0014	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.26e-05	0.00139	CbGpPWpGaD
Cefdinir—Nausea—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000372	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.19e-05	0.00138	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.98e-05	0.00134	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.98e-05	0.00134	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.87e-05	0.00132	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.87e-05	0.00132	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.81e-05	0.00131	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.77e-05	0.0013	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.73e-05	0.00129	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.7e-05	0.00129	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.66e-05	0.00128	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.62e-05	0.00127	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.4e-05	0.00123	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.1e-05	0.00117	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.94e-05	0.00114	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.93e-05	0.00114	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.85e-05	0.00112	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.84e-05	0.00112	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.66e-05	0.00109	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.57e-05	0.00107	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.5e-05	0.00106	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.43e-05	0.00104	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.41e-05	0.00104	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.34e-05	0.00103	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.04e-05	0.000968	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.02e-05	0.000964	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.97e-05	0.000955	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.81e-05	0.000923	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.68e-05	0.000899	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.66e-05	0.000895	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.62e-05	0.000887	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.6e-05	0.000884	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.58e-05	0.00088	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.54e-05	0.000872	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.49e-05	0.000863	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.46e-05	0.000857	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.39e-05	0.000843	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.17e-05	0.000801	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.1e-05	0.000788	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.05e-05	0.000779	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.8e-05	0.000731	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.76e-05	0.000723	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.7e-05	0.000711	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.53e-05	0.000678	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.47e-05	0.000667	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.01e-05	0.000579	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.8e-05	0.000537	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.75e-05	0.000528	CbGpPWpGaD
